Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$39,368
in 1 filing

Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$39K President and CEO sold 5% of stake

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-02-16 Clark Mitchall G. Chief R & QA Officer Exercise or conversion · Restricted Stock Unites −7,211 62,500
2016-02-16 Ciechanover Isaac E. Chief Executive Officer Exercise or conversion +5,908 217,321
2016-02-16 Ciechanover Isaac E. Chief Executive Officer Exercise or conversion · Restricted Stock Units −5,908 45,292
2016-02-16 MCGRATH JOHN Chief Financial Officer Exercise or conversion +2,804 82,017
2016-02-16 MCGRATH JOHN Chief Financial Officer Exercise or conversion +7,697 89,714
2016-02-16 MCGRATH JOHN Chief Financial Officer Sale −6,000 $15.49 $93K 83,714
2016-02-16 MCGRATH JOHN Chief Financial Officer Exercise or conversion · Restricted Stock Units −2,804 12,153
2016-02-16 MCGRATH JOHN Chief Financial Officer Exercise or conversion · Restricted Stock Units −7,697 59,014
2016-02-09 Haqq Christopher Chief Medical Officer Grant or award +55,900 297,619
2016-02-09 Clark Mitchall G. Chief R & QA Officer Grant or award +42,857 77,642
2016-02-09 Turner Heather D VP, General Counsel & Sec. Grant or award +48,857 48,857
2016-02-09 Soffer Gad Chief Operating Officer Grant or award +48,447 120,460
2016-02-09 MCGRATH JOHN Chief Financial Officer Grant or award +42,857 79,213
2016-02-09 Ciechanover Isaac E. Chief Executive Officer Grant or award +163,973 211,413
2016-01-14 Ciechanover Isaac E. Chief Executive Officer Sale −1,200 $20.07 $24K 379,211
2016-01-13 Ciechanover Isaac E. Chief Executive Officer Sale −1,200 $20.32 $24K 380,411
2016-01-04 SEIDENBERG BETH C Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,500 10,500
2016-01-04 HEIDEN WILLIAM K Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,500 10,500
2016-01-04 MARCUS JOEL S Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,500 10,500
2016-01-04 Fust Matthew K Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,500 10,500

Page 56 of 71 · 1,403 trades